point to ponder whilst things are quiet

As the world ponders the possibility of GFC2 its population just keeps on growing at a rate of about 2.5million people per week.

In a nutshell the world of diagnostics just keeps on growing its customer base.

All holds up well if your a Company with the ability to seize a large exposure in this market.

At a 20% discount to where it was only two weeks ago, I suspect the risk reward ratio has improved significantly for this stock based upon the same fundamentals it had two weeks ago.

Other than that - nothing has changed - still awaiting for a sign of ink on paper.

IMO
DYOR